MX2020001786A - Compuesto pentaciclico. - Google Patents
Compuesto pentaciclico.Info
- Publication number
- MX2020001786A MX2020001786A MX2020001786A MX2020001786A MX2020001786A MX 2020001786 A MX2020001786 A MX 2020001786A MX 2020001786 A MX2020001786 A MX 2020001786A MX 2020001786 A MX2020001786 A MX 2020001786A MX 2020001786 A MX2020001786 A MX 2020001786A
- Authority
- MX
- Mexico
- Prior art keywords
- pentacyclic compound
- compound
- pentacyclic
- formulas
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención proporciona compuestos representados por las fórmulas (I) a (VI) o sales farmacéuticamente aceptables de estos. (ver Fórmulas).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017172169 | 2017-09-07 | ||
PCT/JP2018/032797 WO2019049869A1 (ja) | 2017-09-07 | 2018-09-05 | 五環式化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020001786A true MX2020001786A (es) | 2022-09-13 |
Family
ID=65517037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020001786A MX2020001786A (es) | 2017-09-07 | 2018-09-05 | Compuesto pentaciclico. |
Country Status (33)
Country | Link |
---|---|
US (1) | US10239889B1 (es) |
EP (1) | EP3680243B1 (es) |
JP (1) | JP6557441B1 (es) |
KR (1) | KR102307738B1 (es) |
CN (1) | CN111051316B (es) |
AR (1) | AR112788A1 (es) |
AU (1) | AU2018330578B2 (es) |
BR (1) | BR112020003197A2 (es) |
CA (1) | CA3072740A1 (es) |
CL (1) | CL2020000376A1 (es) |
CO (1) | CO2020001471A2 (es) |
CY (1) | CY1125355T1 (es) |
DK (1) | DK3680243T3 (es) |
ES (1) | ES2903172T3 (es) |
HR (1) | HRP20220019T1 (es) |
HU (1) | HUE056791T2 (es) |
IL (1) | IL272652B (es) |
JO (1) | JOP20200030A1 (es) |
LT (1) | LT3680243T (es) |
MA (1) | MA50093B1 (es) |
MD (1) | MD3680243T2 (es) |
MX (1) | MX2020001786A (es) |
PH (1) | PH12020500341A1 (es) |
PL (1) | PL3680243T3 (es) |
PT (1) | PT3680243T (es) |
RS (1) | RS62796B1 (es) |
RU (1) | RU2754557C1 (es) |
SG (1) | SG11202001240XA (es) |
SI (1) | SI3680243T1 (es) |
TW (1) | TWI707859B (es) |
UA (1) | UA125940C2 (es) |
WO (1) | WO2019049869A1 (es) |
ZA (1) | ZA202000970B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3074641A1 (en) | 2017-09-07 | 2019-03-14 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
CN109467538A (zh) | 2017-09-07 | 2019-03-15 | 和记黄埔医药(上海)有限公司 | 环烯烃取代的杂芳环类化合物及其用途 |
TW202100531A (zh) * | 2019-03-05 | 2021-01-01 | 日商衛材R&D企管股份有限公司 | 五環化合物之鹽及其等之結晶 |
BR112021015975A2 (pt) * | 2019-03-05 | 2021-10-05 | Eisai R&D Management Co., Ltd. | Composto heterocíclico pentacíclico |
EP4069369A4 (en) * | 2019-12-06 | 2024-02-14 | Schrödinger, Inc. | CYCLIC COMPOUNDS AND METHODS OF USE THEREOF |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187306A (en) | 1977-07-26 | 1980-02-05 | Bayer Aktiengesellschaft | Benzodiazepine-diones, a process for their production and their use as medicaments |
DD258234A1 (de) * | 1987-03-05 | 1988-07-13 | Univ Leipzig | Verfahren zur herstellung von pyrido/3',2':4,5/thieno/2,3-e/imidazo-/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidine |
RU2117670C1 (ru) * | 1988-10-31 | 1998-08-20 | Эйсай Ко., Лтд. | Производные триазоло[1,4]диазепина и способы их получения |
TW197442B (es) * | 1990-02-08 | 1993-01-01 | Pfizer | |
KR100203456B1 (ko) | 1995-06-20 | 1999-06-15 | 한승수 | 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제 |
FR2779652B1 (fr) * | 1998-06-15 | 2001-06-08 | Sod Conseils Rech Applic | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
CN101084220B (zh) * | 2004-10-20 | 2010-12-15 | 弗·哈夫曼-拉罗切有限公司 | 卤素取代的苯并二氮杂*衍生物 |
JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
US8192080B2 (en) | 2007-01-23 | 2012-06-05 | Tsi Technologies Llc | Microwire-controlled autoclave and method |
-
2018
- 2018-09-05 PL PL18853415T patent/PL3680243T3/pl unknown
- 2018-09-05 CA CA3072740A patent/CA3072740A1/en active Pending
- 2018-09-05 HU HUE18853415A patent/HUE056791T2/hu unknown
- 2018-09-05 RU RU2020106798A patent/RU2754557C1/ru active
- 2018-09-05 PT PT188534150T patent/PT3680243T/pt unknown
- 2018-09-05 US US16/122,116 patent/US10239889B1/en active Active
- 2018-09-05 LT LTEPPCT/JP2018/032797T patent/LT3680243T/lt unknown
- 2018-09-05 AR ARP180102517A patent/AR112788A1/es unknown
- 2018-09-05 ES ES18853415T patent/ES2903172T3/es active Active
- 2018-09-05 SG SG11202001240XA patent/SG11202001240XA/en unknown
- 2018-09-05 CN CN201880053052.1A patent/CN111051316B/zh active Active
- 2018-09-05 UA UAA202000934A patent/UA125940C2/uk unknown
- 2018-09-05 KR KR1020207004232A patent/KR102307738B1/ko active IP Right Grant
- 2018-09-05 RS RS20220015A patent/RS62796B1/sr unknown
- 2018-09-05 DK DK18853415.0T patent/DK3680243T3/da active
- 2018-09-05 WO PCT/JP2018/032797 patent/WO2019049869A1/ja unknown
- 2018-09-05 AU AU2018330578A patent/AU2018330578B2/en active Active
- 2018-09-05 HR HRP20220019TT patent/HRP20220019T1/hr unknown
- 2018-09-05 IL IL272652A patent/IL272652B/en unknown
- 2018-09-05 BR BR112020003197-6A patent/BR112020003197A2/pt unknown
- 2018-09-05 SI SI201830467T patent/SI3680243T1/sl unknown
- 2018-09-05 JO JOP/2020/0030A patent/JOP20200030A1/ar unknown
- 2018-09-05 MD MDE20200725T patent/MD3680243T2/ro unknown
- 2018-09-05 TW TW107131095A patent/TWI707859B/zh active
- 2018-09-05 JP JP2019516726A patent/JP6557441B1/ja active Active
- 2018-09-05 MA MA50093A patent/MA50093B1/fr unknown
- 2018-09-05 EP EP18853415.0A patent/EP3680243B1/en active Active
- 2018-09-05 MX MX2020001786A patent/MX2020001786A/es unknown
-
2020
- 2020-02-11 CO CONC2020/0001471A patent/CO2020001471A2/es unknown
- 2020-02-13 CL CL2020000376A patent/CL2020000376A1/es unknown
- 2020-02-14 ZA ZA2020/00970A patent/ZA202000970B/en unknown
- 2020-02-14 PH PH12020500341A patent/PH12020500341A1/en unknown
-
2022
- 2022-01-10 CY CY20221100025T patent/CY1125355T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202102549B (en) | Substituted tolyl as fungicides | |
AU2018258581A8 (en) | RAF-degrading conjugate compounds | |
PH12020500341A1 (en) | Pentacyclic compound | |
SI3577110T1 (sl) | 8-oksetan-3-IL-3,8-diazabiciklo(3.2.1)oktan-3-IL substituirane spojine kot zaviralci HIV-a | |
PH12016501813B1 (en) | 1,3-benzodioxole derivative | |
MA39749A (fr) | Dérivés de pipéridine-dione | |
EP4219526A3 (en) | Method for preparing amg 416 | |
AU2018293627A1 (en) | New azaquinoline derivatives | |
PH12016501252A1 (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
MX2017016030A (es) | Derivado de dihidropirrolopirazol sustituido. | |
MX2018001517A (es) | Derivados sustituidos de guanidina. | |
PH12018500903A1 (en) | Pyranodipyridine compound | |
WO2018101663A3 (ko) | 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법 | |
MX2017014549A (es) | Farmacos precursores de oxabicicloheptanos. | |
PH12018500282A1 (en) | Cgrp receptor antagonists | |
IL284800A (en) | Methods, uses and compositions | |
PH12020550649A1 (en) | Anti-hbv tetrahydroisoxazolo[4,3-c]pyridine compounds | |
PH12017501404A1 (en) | Diaza-benzofluoranthrene compounds | |
MX2019002065A (es) | Derivado de triazolopirazinona util como un inhibidor de pde1 humana. | |
MX2016013439A (es) | Formas solidas de un compuesto farmaceuticamente activo. | |
IL282905A (en) | Cycloalkane-1, 3-diamine derivative | |
MX2016017019A (es) | Metodo para la preparacion de 4-alcoxi-1,1,1-trifluorobut-3-en-2-o nas de 1,1,1 trifluoroacetona. | |
MX2019007786A (es) | Compuestos sustituidos de guanidina. | |
MY174415A (en) | Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof | |
MX2022006984A (es) | Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina. |